IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8952004 B1

PDFFull Text
Date of Patent:
Feb. 10, 2015

Filed:

Jan. 05, 2011

Cxcr3 receptor antagonists

Applicants:

John David Ginn, New Milford, CT (US);

Ronald John Sorcek, Bethel, CT (US);

Michael Robert Turner, Danbury, CT (US);

Di Wu, Danbury, CT (US);

Frank Wu, Ridgefield, CT (US);

Inventors:

John David Ginn, New Milford, CT (US);

Ronald John Sorcek, Bethel, CT (US);

Michael Robert Turner, Danbury, CT (US);

Di Wu, Danbury, CT (US);

Frank Wu, Ridgefield, CT (US);

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:

Michael P. Morris

Edward S. Lazer

Primary Examiner:

Emily Bernhardt

Int. Cl.
CPC ...
A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/08 (2006.01); C07D 407/14 (2006.01); C07D 211/26 (2006.01); C07D 211/32 (2006.01); C07D 213/74 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 487/06 (2006.01); C07D 497/04 (2006.01); A61K 31/553 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07D 407/14 (2013.01); C07D 211/26 (2013.01); C07D 211/32 (2013.01); C07D 213/74 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 409/14 (2013.01); C07D 413/06 (2013.01); C07D 413/14 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/06 (2013.01); C07D 497/04 (2013.01);
Abstract

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Rto R, A, B, X, and n are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Find Patent Forward Citations

Loading…